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Objective: An ideal valved conduit o repair complex congenital heart defects is 
yet to be developed. In this study we have evaluated the merits of our newly 
developed calcification-free biologic valve incorporated in a compatible conduit 
of biologic origin in an animal model. Methods: Porcine aortic valves and main 
pulmonary arteries were cross-linked in glutaraldehyde, followed by coupling 
to partially degraded heparin through an intermediate surface-bound sub- 
strate containing amino groups. Because commercially available valves are 
treated only with glutaraldehyde, control aortic valves and main pulmonary 
arteries were cross-linked in 0.625% g!utaraldehyde. Valved conduits were 
fabricated from main pulmonary arteries, which were sewn to the aortic and 
ventricular ends of aortic valves. Valved conduits were examined for calcifica- 
tion and other pathologic hanges after being implanted in the descending 
thoracic aorta in juvenile sheep for 5 months. Results: Severe calcification was 
noticed in all layers of cusps (calcium, 231.86 - 17.90 mg/gm) and aortic wall 
(calcium, 123.24 _ 24.72 mg/gm) of aortic valves and main pulmonary arteries 
(calcium, 135.43 ~ 26.63 mg/gm) of valved conduits treated with 0.625% 
glutaraldehyde. Cusps (calcium, 1.28 -+ 0.22 mg/gm) of the aortic valve of 
heparin-bonded conduits did not calcify at all. Only sparse calcific deposits 
were noticed in the medial layer of the aortic wall (calcium, 25.90 - 22.79 
mg/gm) of aortic valves and main pulmonary arteries (calcium, 9.64 -+ 10.79 
mg/gm) of the valved conduits coupled to heparin. Conclusion: Heparin 
coupling is effective in preventing calcification of glutaraldehyde cross-linked 
valved conduits implanted in the systemic circulation of juvenile sheep. 
(J Thorac Cardiovasc Surg 1997;114:218-23) 
R b epair of complex congenital cardiac anomalies Loften requires the use of extracardiac conduits. 
Various types of conduits, such as irradiated and 
frozen homografts, Dacron conduits containing 
glutaraldehyde-treated porcine aortic valves (AVs), 
mechanical valves incorporated in Dacron tubes, 
and more recently crY0preserved aortic or pulmo- 
nary homografts, have been used. Early calcification 
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and degeneration are the main causes of failure of 
irradiated and frozen homografts and glutaralde- 
hyde-treated porcine xenografts. Pseudointimal pro- 
liferation is the main cause of obstruction of Dacron 
conduits. In 1966, Ross and Somerville 1 used an 
aortic allograft to repair pulmonary atresia with a 
ventricular septal defect. Since then, allograft valved 
conduits have been the best available biologic sub- 
. 9-4 stitutes for children." However, early degeneration 
and progress!ve calcification have limited the dura- 
bility of the allograft valves in pediatric patients. 2'5-8 
These facts prompted us to develop a calcification- 
free biologic valve incorporated in a compatible 
conduit of biologic origin. 
Materials and methods 
Groups 1 and 2. Porcine AVs and main pulmonary 
arteries (MPAs) were cross-linked in glutaraldehyde 
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(Glutaraldehyde EM 25%, TAAB Laboratories Equip- 
ment Ltd., Reading, United Kingdom) in normal saline 
solution (pH 7.4) with gradually increasing concentrations 
of glutaraldehyde from 0.1% to 0.25% in normal saline 
solution at 37 ° C for 1 month. After glutaraldehyde treat- 
ment, subannular tissues of the AV were trimmed to 
approximately 2 mm from the base of the leaflets, and the 
MPA grafts were sewn to the ventricular and aortic ends 
of the valves with 5-0 anc! 4,0 polypropylene, respectively 
(arrangement: MPA-AV-MPA). Glutaraldehyde-treated 
valved conduits Were coupled to 0.1% partially degraded 
heparin (depo!ymerized by deaminative cleavage with 
nitrous acid). For covalent binding of heparin to these 
valved conduits, an intermediate surface-bound substrate 
containing amino groups was used. This intermediate 
surface-bound substrate containing amino groups was 
prepared by coupling 0.1% chitosan (Sigma Chemical Co., 
St. Louis, Mo.) and 0.015% gentamicin sulfate (Schering- 
Plough, Osaka, Japan) to free aldehyde groups of glutar - 
aldehyde already bound to the valved conduit. The par- 
tially degraded heparin was coupled with stable covalent 
bonds to aminated surfaces of glutaraldehyde-treated 
valved conduits by reduction with sodium borohydride at 
pH 8.4. Valved conduits without heparin and with heparin 
bonding were grouped as follows: group 1 (treatment with 
glutaraldehyde, chitosan, and gentamicin) and group 2 
(treatment with glutara!dehyde , chitosan, gentamicin, and 
heparin). 
Group 3. The AV and MPA were cross-linked with 
0.625% glutaraldehyde in phosphate buffer solution 
(0.067 tool/L, pH 7.4) at 2 ° to 4 ° C for 24 hours followed 
by preservation i  0.2% glutaraldehyde in the same buffer 
at 2 ° to 4°C for more than 4 weeks. Valved conduits 
treated with 0.625% glutaraldehyde were fabricated like 
valved conduits of groups 1 and 2. 
Implantation in sheep. Valved conduits of different 
groups were inserted in the descending thoracic aorta of 
21 (n = 7 for each group) 6-week-old juvenile sheep 
weighing 10.5 to 12 kg. All animals received humane care 
in compliance With the "Principles of Laboratory Animal 
Care," formulated by the National Society for Medical 
Research, and the "Guide for the Care and Use of 
Laboratory Animals," prepared by the Institute of Labo- 
ratory Animal Resources and published by the National 
Institutes of Health (NIH Publication No. 80-23, revised 
1985). Surgical technique of implantation of the valved 
conduits was similar to that described elsewhere. 9 In brief, 
recipient sheep were preanesthetized with intramuscular 
ketamine (15 mg/kg). After additional anesthesia with 
intravenous pentobarbital sodium (30 mg/kg), sheeP were 
endotracheally intubated and a 0.1 mg/kg dose of pancu- 
ronium was administered. Ventilation was maintained 
with a mixture of room air and oxygen. Under aseptic 
conditions, a left thoracotomy incision was performed 
through the fifth intercostal space. The descending tho- 
racic aorta, distal to the subclavian artery and 4 to 5 cm in 
length, was mobilized, proximally crossclamped, and Cut at 
the' middle of the mobilized part. After heparinization 
(100 units/kg), a temporary apicoaortic shunt was estab- 
lished with a piece of heparin-coated polyvinylchloride 
tube. Elastic recoil of the transected aorta Permitted a
valved conduit 5 cm long (internal diameter 16.5 + 1.5 
mm) to be inserted. Proximal and distal ends of the valved 
conduit were anastomosed to the cut ends of the descend- 
ing thoracic aorta in end-to-end fashion with continuous 
5-0 polypropylene, and the shunt was discontinued. The 
chest ube was removed immediately on completion of the 
skin suture. Intravenous cefazolin 2 gm (Cefamezin, Fu- 
jisawa Pharmaceuticals, Osaka, Japan) and amikacin 100 
mg (Banyu Pharmaceuticals, Tokyo, Japan) were rou- 
tinely administered before the operation. Amikacin 100 
mg was repeated twice daily for 5 days after the operation. 
Five months after implantation, the valved conduit with 
part of the adjacent aorta was removed en bloc, grossly 
examined, and incised longitudinally. A longitudinal sec- 
tion of the valved conduit was preserved in 10% formalin 
solution for histologic study. Histol0giC sections were 
stained with hematoxylin and eosin and von Kossa stains 
for general morphology and calcification study. Remain- 
ing portions of the cusps, the aortic wall of the porcine 
AV, and the MPA of the explanted valved conduit were 
carefully excised and individually lyophilized for estima- 
tion of calcium content by atomic absorption spectros- 
copy, as mentioned elsewhere. 9 Statistical analyses were 
carried out with two-tailed unpaired t tests. Significant 
differences were considered to exist at the p < 0.01 level. 
Results 
General assessment.  Paraparesis developed in 
one sheep of group 1 as a result of excessive division 
of intercostal arteries. This sheep was killed elec- 
tively 3 months after the operation so that the 
pathologic hanges of the implanted valved conduit 
could be observed. Histopathologic examination 
showed severe calcification of the valved conduit. 
Another sheep of this group died 12 hours after the 
operation of intraoperative bleeding. One sheep of 
group 2 died suddenly 21 days after the operation. 
This animal had ventricular tachycardia, which was 
successfully managed, after the aorta was un- 
clamped. Postmortem examination revealed no dis- 
ease of systemic organs, and the valved conduit was 
completely free of thrombus. Histochemically, cal- 
cification of the valved conduit was not identified. 
One sheep of group 3 died suddenly 3 months after 
the operation. This sheep had no other pathologic 
abnormalities of systemic organs except severe cal- 
cification of the implanted valved conduit. All these 
four sheep were excluded from our study. The 
surviving 17 sheep (group 1, n - 5; group 2. n = 6: 
and group 3. n = 6) did well through the planned 
5-month implantation period, and their preopera- 
tive weights more than doubled over 5 months. 
Continuous pressure measurements showed no 
transconduit gradient in any sheep except in one of 
group 3, in which the transconduit gradient was 20 
mm Hg. Seventeen valved conduits were examined 
morphologically after having been implanted for 5 
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Fig. 1. Gross view of a longitudinally sectioned valved 
conduit treated with 0.625% glutaraldehyde (group 3), 
implanted in a juvenile sheep for 5 months, demonstrates 
severe calcification of cusps and conduit wall. Surface 
thrombi (dark) in one sinus of Valsalva (middle) and at 
both anastomotic sites of the valve with the MPA can be 
seen. Note that flattening caused fracture of the conduit 
wall and cusps. 
Fig. 2. Longitudinal section of a heparin-coupled glutar- 
aldehyde-treated valved conduit (group 2) implanted in 
the descending thoracic aorta of a juvenile sheep for 5 
months. Grossly, in comparison with Fig. 1, no pathologic 
changes of cusps and conduit wall can be noticed. 
months. Valved conduits of groups 1 and 3 were 
hard and tenaciously adherent to the left lung and 
adjacent parts of the ribs and vertebrae, whereas 
valved conduits of group 2 were soft and adhered 
only to the lungs. All cusps of explanted valved 
conduits of groups 1 and 3 were rigid, friable, thick, 
and completely calcified (Fig. 1). The flexibility of 
the conduit walls of the valved conduits of both 
groups 1 and 3 was totally lost. Flattening of the 
incised conduits caused fracture of completely cal- 
cified walls and detachment of calcific plaques (Fig. 
Fig. 3. Transverse section of a heparin-bonded glutaral- 
dehyde-treated valved conduit (group 2) implanted in a 
sheep for 5 months. No thrombi and fibrous peel can be 
seen on the outflow surface of leaflets of the valve. 
1). In contrast, the conduit walls of the valved 
conduits of group 2 were soft and flexible, and 
flattening of the incised conduits did not cause any 
change (Fig. 2). Cusps of valved conduits of this 
group were absolutely unchanged (Fig. 3). Neither 
dissection nor aneurysmal dilation was detected 
elsewhere in any conduit of any group. 
Histologic findings. Thinning of the conduit wall 
was not observed in any group. Severe calcification 
of intima, media, and adventitia was noticed both in 
the aortic wall and in the MPA of the valved 
conduits of groups 1 and 3. Fracturing of calcified 
intima and adventitia of the conduit (both MPA and 
aortic wall) was prominent in all explants of groups 
1 and 3. Severe calcification of cusps was revealed in 
all valved conduits of these groups (Fig. 4). Diffuse 
calcification was noticed in the fibrosa, and the 
spongiosa was severely affected. In some specimens 
histologic sectioning caused separation of ventricu- 
laris from spongiosa. Ventricularis was less calcified 
than the other two layers. Only sparse calcific de- 
posits were noticed in the medial ayer of the aortic 
wall and MPA of the valved conduits of group 2. 
Calcific changes of the aortic wall of the valved 
conduits of this group were identified mainly above 
the level of the commissures. Basal ring and muscle 
shelf of the AV were completely free of calcification. 
Cusps of the valved conduits of group 2 had not 
calcified at all at 5 months (Fig. 5). 
Calcium content. Calcium content of the cusps 
(calcium = 186.58 _+ 35.20 rag/gin dry tissue 
weight) of valved conduits of group 1 did not 
significantly differ from that of the cusps (calci- 
um --- 213.86 _+ 17.90 mg/gm; p = 0.05) of valved 
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Fig. 4. Morphologic features of calcification of a cusp of valved conduit from group 3, in place for 5 
months. Both the cusp (top) and aortic wall (bottom) are calcified. Dense calcific deposits damaged the 
spongiosa of the cusp completely. Histologic sectioning probably promoted etachment of the spongiosa 
itself. (von Kossa stain; original magnification ×50.) 
Fig. 5. Histologic appearances of a cusp of a valved conduit from group 2, implanted in the descending 
thoracic aorta in a juvenile sheep for 5 months. No calcific deposits were observed in the cusp (top) or in 
the aortic wall (bottom, below the level of the commissures) of the valve. (von Kossa stain; original 
magnification ×50.) 
conduits of group 3. The calcium content of the 
cusps of valved conduits of group 2 was only 
1.28 _+ 0.22 mg/gm. This value was significantly 
lower than that of group 1 or 3 (p < 0.0001). 
Calcium contents of the aortic wall (group 1: 
calcium = 111.94 _+ 27 mg/gm; group 3: calcium -- 
123.24 _+ 24.72 mg/gm) and the MPA (group 1: 
calcium = 122.87 _+ 29.01; group 3: calcium = 
135.43 +_ 26.63 rag/gin) of valved conduits of both 
groups 1 and 3 were virtually identical. However, 
the calcium levels of the MPAs and aortic walls of 
valved conduits of group 2 were 9.64 + 10.79 and 
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25.90 _+ 22.79 mg/gm (group 2 vs group 1 or 3,p = 
< 0.0001), respectively. 
Discussion 
Our present experimental study yields the following 
conclusions: (1) Complete prevention of calcifica- 
tion of the cusps of glutaraldehyde-treated porcine 
AVs may be achieved by coupling of heparin to the 
valve; (2) heparin binding inhibits the calcification 
of the aortic wall of the glutaraldehyde-treated AV; 
(3) the proposed anticalcification treatment is more 
effective in the porcine pulmonary artery than in the 
aortic wall of the AV. 
True aneurysms of pulmonary allograft patches, 
suture-line pseudoaneurysms of pulmonary allo- 
grafts, 19 and even rupture! 1 occurred in clinical 
practice when pulmonary allografts were subjected 
to systemic pressure. While standardizing our exper- 
imental model, we used valves attached to Dacron 
conduits. Because the addition of a valve to the 
Dacron conduit appeared to accelerate pseudo- 
intima formation, as observed by other investiga- 
tors, 1244 we have abandoned Dacron grafts and 
decided to use the porcine MPA as a conduit. 
Distensibility is greater and the tendency toward 
calcification is reduced in MPAs in lambs. 15 With 
our proposed anticalcification treatment, he MPAs 
of group 2 had much less tendency toward calcifica- 
tion than did the aortic walls of the same group. 
However, none of the MPAs of either group became 
distended in our study. Severe calcification was the 
main feature of pathologic hanges of all conduits of 
groups 1 and 3. Neither pseudoaneurysm nor dissec- 
tion was observed at any anastomotic site of valved 
conduits implanted in the descending thoracic aorta 
in juvenile sheep at 5 months. 
Heparin has been known to be effective in pre- 
venting calcified atherosclerotic plaque formation in 
major arteries. 16 Heparin has a potent antigrowth 
effect in smooth muscle cells, ~7 and it also binds to 
the surface of cells. 1S This may alter permeability o 
ions necessary for growth, change confirmation of 
molecules to which it binds, 19 or affect cell volume. 2° 
The exact role of heparin in the anticalcification 
process of bioprostheses still remains elusive. Con- 
ceivably, coupling of heparin to glutaraldehyde- 
treated grafts fills the intertropocollagen spaces, 
blocks the potential binding sites, modifies charges, 
and thus makes the prostheses impermeable to host 
plasma calcium. 
Heparin is as effective in preventing calcification 
of the porcine pulmonary valve as of the porcine AV 
(unpublished ata). The heparin-bonded porcine 
pulmonary valve extended proximally with a pulmo- 
nary artery may also serve as a prospective valved 
conduit. 
Sterilization of fresh homografts with antibiotics, 
as well as preservation or cryopreservation, has 
resulted in a resurgence in the use of aortic ho- 
mografts. 3 Concern has been expressed, however, 
about calcification of these homografts in the pul- 
monary position. 21 The rate of calcification of ho- 
mografts used for reconstruction of the right ven- 
tricular outflow tract appears to be accelerated in
younger children and in patients with pulmonary 
hypertension. 22 Although the cryopreserved pulmo- 
nary allograft appears to be the conduit of choice for 
reconstruction f the right ventricular outflow tract, 3
the prevalence of aortic allograft fibrocalcification 
and valvular insufficiency warrants reexamination of
the surgical options available for young children 
with congenital anomalies of the left ventricular 
outflow tract. 23 Because the homografts calcify 
much faster in high-pressure systems 22' 23 than in the 
usual pressure of the pulmonary circulation, and the 
juvenile sheep is a good animal model for the study 
of accelerated calcification of cardiovascular bio- 
prostheses, 24 we have designed our experiment to 
implant the treated valved conduit in the systemic 
circulation in juvenile sheep. 
Preliminary studies show the satisfactory results 
with proposed chemical treatment in preventing 
calcification of porcine AV conduits implanted in 
the systemic circulation in juvenile sheep for 5 
months. However, long-term study is necessary be- 
fore the valved conduits can be recommended for 
use in patients. 
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